Domestic markets navigated a volatile week, ending near all-time highs. Bajaj Finance filed for a Rs 7,000 crore IPO, Kronox Lab to debut with 30% premium, Godawari Power eyes share buyback, Dr Reddy’s unit gets FDA observations, and Jubilant Pharmova faces FDA scrutiny.
IndusInd’s back in black for Q4 with Rs 594 cr profit; provisions, slippages fall
In a remarkable financial turnaround, IndusInd Bank reported a net profit of ₹594 crore for the quarter ending March 2026. This surge was largely due
April 25, 2026